Come up with a name for your new list and we'll add to it:
Diffusion Pharmaceuticals raised a round of funding on February 11, 2010. Investors include
US Office of Naval Research.
Diffusion Pharmaceuticals is a clinical-stage company developing drugs which target the unmet medical needs characterized by oxygen deprivation (hypoxia) at the cellular level. These small molecules w…